Wednesday, April 13, 2022 12:00 - 2:00 P.M. EDT
Target Audience:
These clinical presentations will be of interest to physicians, physician assistants, pharmacists, nurse practitioners and nurses. Other disciplines are welcome to attend.
“Emerging HIV Treatment Options” Learning Objectives:
Describe the role of cabotegravir/rilpivirine injectable for the treatment of HIV.
Discuss injectable and other novel formulations in development for HIV treatment and prevention, including route of administration, dosing schedules, and approval timelines.
Review shifting treatment paradigms, two vs three drugs for HIV treatment.
“COVID-19 Hot Topics” Learning Objectives:
Describe SARS-CoV-2 and its role in causing COVID-19, including pathogenesis, therapeutic targets, current circulating variants.
Discuss the management and prevention of COVID-19, including vaccines, monoclonal antibodies, antiviral medications, and an approach to selecting therapies.
Discuss the new and evolving landscape of COVID-19 treatments.
Register to attend here.